Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA localised rash after a Mounjaro injection is one of the most common skin reactions people notice, and in the majority of cases it is a mild, short-lived response at the injection site rather than a sign that something is seriously wrong. That said, not every rash is the same, and knowing which type you are dealing with shapes what you should do next. Mounjaro (tirzepatide) is a prescription-only medicine, and any skin reaction that concerns you is worth discussing with the prescriber who oversees your treatment, who can advise based on your specific history and current dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first decision is straightforward: is the rash confined to the injection spot, or is it spreading beyond it? A small area of redness, mild swelling and perhaps some itching or warmth directly where the needle entered the skin is a well-documented local reaction. The NHS tirzepatide medicines page lists injection-site reactions (including redness and pruritus) among the common side effects of Mounjaro, meaning they affect at least one in a hundred people. These local responses typically fade within hours to a couple of days and do not usually require any change to treatment.
A quick check worth doing right now: look at the affected area in good light. Is the redness less than a couple of centimetres across, is the skin unbroken, and does the reaction stay within roughly the zone of the injection itself? If yes to all three, you are most likely looking at a benign local response. A closer look at injection-site rash patterns with Mounjaro covers the visual differences in more detail.
If the rash is spreading outward from the injection point, is accompanied by raised welts, or if you are experiencing any breathing difficulty, a swollen tongue, dizziness or a racing heartbeat, those are signs of a possible systemic allergic reaction. Stop the injection if mid-dose, call 999 and tell them you have received an injectable medicine. Do not wait to see if it settles.
Tirzepatide is delivered under the skin, where immune cells can react to the formulation or to the mechanical act of injection itself. Several factors feed into how much local inflammation occurs. Injecting repeatedly into the same patch of skin, using a blunt or re-used needle, injecting cold liquid straight from the fridge, or not allowing the alcohol from a swab to dry fully before the needle goes in — any of these can make the skin respond more strongly than it otherwise would.
Dose changes can also trigger a short-lived uptick in reactions. Some people who had no problem at 2.5mg notice more site sensitivity after moving up, which often settles again once the body adjusts at the new dose. If you have found certain sites more reactive than others, it is worth experimenting: the abdomen, outer thigh and back of the upper arm are all licensed injection sites, and cycling between them gives each area time to recover. For those who find standard needles cause more discomfort or trauma, shorter, finer needles for Mounjaro are available separately and may reduce local irritation.
If you want to understand what typically causes a rash after injecting Mounjaro, including how the body's immune cells respond to repeated subcutaneous delivery, the fuller guide goes into the biological mechanism in more detail for those who want it.
Once you have ruled out anything urgent, the focus shifts to prevention. Let the pen sit at room temperature for around 30 minutes before injecting, cold formulation is harder on the tissue. Rotate sites systematically rather than picking the most convenient spot each week; a simple mental rotation (abdomen this week, thigh next, upper arm the week after) makes a real difference over time.
Injection technique affects the outcome too. Pinch a good inch of skin, insert at the recommended angle, and release the pinch only after the pen has fully delivered the dose. Alcohol swabs are useful for cleaning the area, but the swab needs to dry completely, a residue of wet alcohol is itself an irritant under the skin. Swap to a new needle every injection without exception; a fresh pen needle is sharper and causes less tissue disruption than one that has been used before.
For persistent or recurring site reactions that do not settle with technique adjustments, speak to your prescriber before your next dose. They may suggest antihistamines before injection on a short-term basis, a temporary pause before re-trying, or review whether the current dose schedule suits you. Never adjust your dose or injection timing on your own.
Most injection-site rashes resolve without intervention. But there are a handful of situations where you should not wait for your next scheduled check-in. Contact your prescriber promptly if: the local reaction is getting worse across several days rather than better; the skin becomes broken, hot and tender in a way that could suggest infection; you develop a rash after your Mounjaro injection in areas away from the injection site; or you experience any of the systemic symptoms described in the first section above.
For symptoms you cannot explain or that feel serious, the NHS 111 service is available around the clock. If you have any doubt, err on the side of calling. People using tirzepatide who want a dedicated guide to a rash at the injection site with tirzepatide, including how reactions with this specific molecule are documented, will find the distinct considerations covered separately, alongside those who notice a rash around the Mounjaro injection site that spreads or changes in character over time.
Suspected reactions to medicines (including injection-site reactions) can be reported to the MHRA via the Yellow Card scheme. You do not need your prescriber to do this on your behalf; anyone can submit a report directly online.
If you are considering starting Mounjaro and want to understand more about how treatment is managed, including what our prescribers look for at each stage, starting your free consultation is the right first step. Every patient at nume (at our GPhC-registered pharmacy) has their treatment reviewed by a real prescriber, not automated software, before anything is dispensed or changed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.